The University of Chicago Header Logo

Connection

Rudolph Navari to Time Factors

This is a "connection" page, showing publications Rudolph Navari has written about Time Factors.
Connection Strength

0.027
  1. A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study. Cancer Invest. 2004; 22(3):383-8.
    View in: PubMed
    Score: 0.008
  2. Comparison of the open skull and cranial window preparations in the study of the cerebral microcirculation. Microvasc Res. 1978 Nov; 16(3):304-15.
    View in: PubMed
    Score: 0.005
  3. Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis. Support Care Cancer. 1997 Jan; 5(1):31-7.
    View in: PubMed
    Score: 0.005
  4. Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group. Cancer Invest. 1997; 15(4):297-303.
    View in: PubMed
    Score: 0.005
  5. Protein turnover in advanced lung cancer patients. Metabolism. 1993 Mar; 42(3):291-6.
    View in: PubMed
    Score: 0.004
  6. Functional, morphological, and metabolic abnormalities of the cerebral microcirculation after concussive brain injury in cats. Circ Res. 1980 Jan; 46(1):37-47.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.